IP that matters: behind Orexo’s patent win against generic giant (NLS Days)

At Nordic Life Science Days, you’ll get a rare inside look at Orexo’s decisive US patent litigation victory over Sun Pharma, a case that proves the power of a rock-solid IP strategy in protecting both innovation and patient impact. 

Hear from those who lived it: 

• Orexo – on the effective use of IP to meet its business objectives, safeguarding lifechanging treatments for opioid dependence; 
• Steptoe -  US litigators who brought and successfully argued the case before the court; and
• Potter Clarkson – Orexo’s patent attorneys who had a key, central role in preparing the ground for that success

Join us on the Flow Stage at 16:30, Monday 13 October for an insightful session.

Because when innovation is under fire, strategy is everything.